论文部分内容阅读
目的 :观察支气管哮喘患者经管理后医疗费用和病情严重度变化情况。方法 :病人分管理组和非管理组 ,按预定的治疗方案和随访原则进行治疗随访 ,比较随访前 6个月和随访后 6个月的医疗费用和症状变化。结果 :管理组和非管理组在随访 6个月后医疗费用均有下降 ,管理组医疗费用显著低于非管理组 (P <0 0 1) ,管理组症状明显好转率显著高于非管理组 (P <0 0 5 ) ,管理组患者主要使用的药物为必可酮 ,非管理组主要使用 β激动剂。结论 :支气管哮喘患者经管理和正确治疗 ,可减少医疗费用和明显改善临床症状。
OBJECTIVE: To observe the changes of the medical costs and the severity of the patients after the management of bronchial asthma. Methods: The patients were divided into non-management group and non-management group according to the planned treatment plan and follow-up principle. The medical costs and symptoms of 6 months before follow-up and 6 months after follow-up were compared. Results: After 6 months of follow-up, the medical expenses decreased, the medical expenses of the management group were significantly lower than those of the non-management group (P <0.01), and the improvement rate of the management group was significantly higher than that of the non-management group (P <0.05). The major drug used in the management group was becquerone, while the non-management group mainly used beta agonist. Conclusion: Management and correct treatment of patients with bronchial asthma can reduce medical costs and significantly improve clinical symptoms.